(via TheNewswire)
Our protein CBD expression program will continue unabated over this period of crisis management. The COVID 19 crisis has delayed the launch of our organic Omega 3 commercial product but we are working with our contractors to reschedule production in the next few months. The demand for health care products will remain just as strong and we may even see this health crisis increase the demand for new and established health care products like omega 3's.
Because of our secure facilities, the Company was approached by the Federal Government to supply laboratory space for "COVID 19" testing but so far we have not been called upon to activate this program.
Solarvest operates in the health care industry, which going forward will be relied upon for solutions for medical, and ongoing wellness needs.
About:
For further information contact:
Tel: 416 420 0947 Email: ggreenham@solarvest.ca
The
Neither
* *GOED Omega 3 Market Presentation -2012 Estimated Global Consumer Spending on Products Containing EPA/DHA Oils.
**https://www.globenewswire.com/news-release/2015/03/16/1434947/0/en/Solarvest-Achieves-Significant-Breakthrough.html
Statements made in this news release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the Company's expectations and projections.
Copyright (c) 2020 TheNewswire - All rights reserved.
Copyright (c) 2020 TheNewswire - All rights reserved., source